论文信息 - Integration of ruxolitinib into dose‐intensified therapy targeted against a novel JAK2 F694L mutation in B‐precursor acute lymphoblastic leukemia - 字舞流文

Integration of ruxolitinib into dose‐intensified therapy targeted against a novel JAK2 F694L mutation in B‐precursor acute lymphoblastic leukemia

C. Nickl | S. Winter | K. Matlawska-Wasowska | J. M. Gale | M. Vasef | S. Ness | G. Pickett | David R. Czuchlewski | Jodi R. Mayfield